Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide Eva PodgoršekNiven MehraNielka P. van Erp Review Article Open access 17 July 2023 Pages: 1049 - 1061
Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor Neeraj GuptaMichael J. HanleyVikram Sinha Review Article Open access 26 July 2023 Pages: 1063 - 1079
Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy Takuto TakahashiMasahiro TeramotoKatsuji Kaida Original Research Article 07 June 2023 Pages: 1081 - 1091
Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment Hengli ZhaoZhirui ZhaoQing Wen Original Research Article 07 June 2023 Pages: 1093 - 1103
Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates Bo-Hao TangJin-Yuan ZhangWei Zhao Original Research Article 10 June 2023 Pages: 1105 - 1116
A Joint Pharmacokinetic Model for the Simultaneous Description of Plasma and Whole Blood Tacrolimus Concentrations in Kidney and Lung Transplant Recipients Jeroen V. KoomenTim J. KnobbeTransplantLines Investigators Original Research Article Open access 12 June 2023 Pages: 1117 - 1128
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients Ruben A. G. van EerdenNikki S. IJzermanthe Dutch Pharmacology Oncology Group Original Research Article Open access 13 June 2023 Pages: 1129 - 1139
The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis Urs DuthalerFabio BachmannStephan Krähenbühl Original Research Article Open access 16 June 2023 Pages: 1141 - 1155
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs J. M. JanssenD. DamoiseauxT. P. C. Dorlo Original Research Article Open access 23 June 2023 Pages: 1157 - 1167
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women Andrea LukesElizabeth MigoyaJuan Camilo Arjona Ferreira Original Research Article Open access 26 June 2023 Pages: 1169 - 1182
Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps” Meng LvShengnan Zhang Letter to the Editor 23 June 2023 Pages: 1183 - 1185
Authors’ Reply to Lv et al.: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps” Mehdi El HassaniAmélie Marsot Letter to the Editor 23 June 2023 Pages: 1187 - 1188